RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical setting
<strong>Background: </strong>RH5 is the leading vaccine candidate for the Plasmodium falciparum blood stage and has shown impact on parasite growth in the blood in a human clinical trial. RH5 binds to Ripr and CyRPA at the apical end of the invasive merozoite form, and this complex, desi...
Hlavní autoři: | Healer, J, Thompson, JK, Mackwell, KL, Browne, CD, Seager, BA, Ngo, A, Lowes, KN, Silk, SE, Pulido, D, King, LDW, Christen, JM, Noe, AR, Kotraiah, V, Masendycz, PJ, Rajagopalan, R, Lucas, L, Stanford, MM, Soisson, L, Diggs, C, Miller, R, Youll, S, Wycherley, K, Draper, SJ, Cowman, AF |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
Frontiers Media
2022
|
Podobné jednotky
-
RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical setting
Autor: Julie Healer, a další
Vydáno: (2022-12-01) -
The RH5-CyRPA-Ripr complex as a malaria vaccine target
Autor: Ragotte, RJ, a další
Vydáno: (2020) -
Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex
Autor: Williams, BG, a další
Vydáno: (2024) -
Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex
Autor: Barnabas G. Williams, a další
Vydáno: (2024-06-01) -
Divergent roles for the RH5 complex components, CyRPA and RIPR in human-infective malaria parasites
Autor: Knuepfer, E, a další
Vydáno: (2019)